Hofseth BioCare ASA (HOFBF)
OTCMKTS · Delayed Price · Currency is USD
0.1666
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Hofseth BioCare ASA Revenue
Hofseth BioCare ASA had revenue of 54.89M NOK in the quarter ending September 30, 2025, a decrease of -19.15%. This brings the company's revenue in the last twelve months to 249.08M, up 0.40% year-over-year. In the year 2024, Hofseth BioCare ASA had annual revenue of 265.54M with 21.52% growth.
Revenue (ttm)
249.08M NOK
Revenue Growth
+0.40%
P/S Ratio
2.83
Revenue / Employee
3.19M NOK
Employees
78
Market Cap
70.64M USD
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265.54M | 47.03M | 21.52% |
| Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
| Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
| Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
| Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| South Dakota Soybean Processors, LLC | 484.17M |
| Hanover Foods | 330.81M |
| Elamex SA de CV | 110.74M |
| Starco Brands | 47.15M |
| Global Pharmatech | 3.18M |
| Limitless X Holdings | 1.13M |
| Goldenwell Biotech | 62.34K |
| UMeWorld | 2.22K |
Hofseth BioCare ASA News
- 2 months ago - Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION - GlobeNewsWire
- 2 months ago - Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING - GlobeNewsWire
- 3 months ago - Hofseth BioCare ASA: Extraordinary General Meeting completed - GlobeNewsWire
- 3 months ago - Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING - GlobeNewsWire
- 3 months ago - Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE - GlobeNewsWire
- 3 months ago - Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering - GlobeNewsWire
- 3 months ago - Hofseth BioCare ASA: Terms of the Subsequent Offering - GlobeNewsWire
- 3 months ago - Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING - GlobeNewsWire